Cardiovascular disease (CVD) is prevalent worldwide and remains a leading cause of
death. Although substantial progress has been made in the diagnosis and treatment of CVD …

Renalase is a novel flavoprotein, highly expressed in kidney and heart, which metabolizes
catecholamines and catecholamine-like substances via a superoxide (O2–)-dependent …

Introduction Exercise training is beneficial for reducing obesity. In particular, exercise
training can lower the catecholamine concentration in circulation. Renalase, whose …

Background/Aims: Renalase, a novel flavoprotein expressed in the kidney and heart,
reduces renal tubular necrosis and apoptosis, which suggests that it might protect against …

Elevated levels of plasma catecholamines accompany ischemic AKI, possibly contributing
the inflammatory response. Renalase, an amine oxidase secreted by the proximal tubule …

Renalase, a recently discovered flavoprotein, which is strongly expressed in the kidney and
heart, effectively metabolizes catecholamines. It was discovered during the search to identify …

AKI is characterized by increased catecholamine levels and hypertension. Renalase, a
secretory flavoprotein that oxidizes catecholamines, attenuates ischemic injury and the …

Renalase is a newly discovered amine oxidase and may lower blood pressure by
metabolizing catecholamines. We have hypothesized that exercise and training may …

Background An increased risk for developing essential hypertension, stroke and diabetes is
associated with single nucleotide gene polymorphisms in renalase, a newly described …

Renalase was discovered as a protein synthesized by the kidney and secreted in blood
where it circulates at a concentration of approximately 3–5 μg/ml. Initial reports suggested …